Funding Round · Insurtech · 2026

Marrow raises $2M seed funding; live with Aviva since March

Marrow raised $2M a funding round on October 25, 2026.

Primary
Marrow
Amount
$2M
Date
October 25, 2026
Sub-sector
Insurtech

Early-stage insurtech funding at modest size; not material for sub-$250M fintech benchmarking. Customer win with Aviva shows some traction but limited strategic insight.

Primary company
Marrow
Counterparty
Not disclosed
Amount
$2M
Event date
October 25, 2026
Sub-sector
Insurtech
HQ
Not disclosed
Structure
Not disclosed
Source published
Not disclosed
Publisher
Coverager

Source: coverager.com